Table 5.
Mechanisms | Intervention | Refs. |
---|---|---|
1) Manipulation of TLR2 vs. TLR4 responses by altering its lipid A structure |
Blockade of hemin- binding proteins? * |
(3, 40) |
2) Upregulation of negative regulators of TLR signalling(IRAK-M) |
Inhibition of IRAK-M activity? ** |
(49) |
3) Induction of TLR2 inside-out signalling in macrophages for CR3-dependent inhibition of IL-12 |
CR3 antagonists (e.g., XVA143) |
(84, 235) |
4) Degradation of essential TLR coreceptors (CD14) or immunostimulatory cytokines |
Gingipain inhibitors (e.g., KYT-1, KYT-36) or anti-gingipain vaccines |
(11, 111, 213) |
5) Instigation of CXCR4/TLR2 cross-talk for suppressing macrophage-mediated clearance |
CXCR4 antagonists (e.g. AMD3100) |
(89) |
The rationale is based on the finding that alteration of lipid A structure is regulated by microenvironmental hemin concentrations (3).
This could be achieved through specific RNA interference or microRNA-based approaches, although upregulation of undesirable inflammatory responses may be a serious side-effect.